Syndax Pharmaceuticals   Report issue

For profit Phase 1 Phase 2
Founded: Waltham MA United States (2005)

Organization Overview

First Clinical Trial
2007
NCT00602030
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Syndax Pharmaceuticals | Syndax Pharmaceuticals, Inc.